MedTrace Logo

Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

NCT05912660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18882

Last updated 2023-06-22

No results posted yet for this study

Summary

The overall project aim is to study outcomes following aortic valve replacement with surgically implanted bioprostheses or TAVI by retrieving data from the main social security carriers in Austria for the years 2010-2020.

Conditions

  • Aortic Valve Disease

Interventions

DEVICE

Aortic Valve Replacement

Aortic Valve Replacement (surgically or TAVI)

Sponsors & Collaborators

  • Sicknessfund Burgenland

    collaborator UNKNOWN

  • Landesklinikum Sankt Polten

    collaborator OTHER

  • Medical University of Vienna

    lead OTHER

Eligibility

Min Age
65 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2020-12-31
Completion
2020-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05912660 on ClinicalTrials.gov